Ascentage Pharma Group International (AAPG) Stock Chart & Stock Price History $25.12 +2.12 (+9.22%) As of 05/21/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Ascentage Pharma Group International Stock Price Performance The Ascentage Pharma Group International (AAPG) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 16.30%, reflecting recent market activity. As of the latest close, Ascentage Pharma Group International traded at $25.12 with a market cap of $2.19 billion and volume of 20,013 shares. Receive AAPG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+10.91%1 Month Performance+16.30%3 Month Performance+18.66% AAPG Stock Chart for Thursday, May, 22, 2025 AAPG Chart by TradingView Ascentage Pharma Group International Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$23.00$25.12+9.22%$25.17$24.4620,013 shs$2.19 billion05/20/2025$23.78$23.00-3.28%$23.23$23.003,328 shs$2.00 billion05/19/2025$22.65$23.78+4.99%$23.85$22.891,967 shs$2.07 billion05/16/2025$22.56$22.65+0.40%$23.30$22.604,835 shs$1.97 billion05/15/2025$23.40$22.56-3.59%$23.25$22.568,364 shs$1.96 billion05/14/2025$24.04$23.40-2.66%$23.99$23.3016,596 shs$2.04 billion05/13/2025$24.20$24.04-0.66%$24.43$23.4924,369 shs$2.09 billion05/12/2025$24.31$24.20-0.45%$24.69$23.0111,360 shs$2.11 billion05/09/2025$25.16$24.31-3.38%$24.50$24.199,839 shs$2.12 billion05/08/2025$24.17$25.16+4.10%$25.16$24.202,663 shs$2.19 billion Get the Latest News and Ratings for AAPG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$25.66$24.17-5.81%$24.76$23.6733,548 shs$2.10 billion05/06/2025$25.30$25.66+1.42%$26.00$24.6337,533 shs$2.23 billion05/05/2025$25.48$25.30-0.71%$25.50$25.1813,192 shs$2.20 billion05/02/2025$25.15$25.48+1.31%$26.00$25.0015,921 shs$2.22 billion05/01/2025$24.43$25.15+2.95%$25.23$24.436,332 shs$2.19 billion04/30/2025$24.20$24.43+0.95%$25.25$24.4320,917 shs$2.13 billion04/29/2025$25.29$24.20-4.31%$24.88$24.097,560 shs$2.11 billion04/28/2025$26.30$25.29-3.84%$25.65$25.035,310 shs$2.20 billion04/25/2025$25.50$26.30+3.14%$26.50$24.9341,147 shs$2.29 billion04/24/2025$23.90$25.50+6.69%$26.13$24.9363,807 shs$2.22 billion04/23/2025$21.60$23.90+10.65%$24.04$22.7054,300 shs$2.08 billion04/22/2025$19.12$21.60+12.97%$22.00$21.04120,047 shs$1.88 billion04/21/2025$18.72$19.12+2.14%$19.93$18.8710,980 shs$1.66 billion Related Companies ROIV Stock Price Chart RVMD Stock Price Chart BPMC Stock Price Chart BBIO Stock Price Chart ELAN Stock Price Chart VRNA Stock Price Chart TLX Stock Price Chart LNTH Stock Price Chart TGTX Stock Price Chart GRFS Stock Price Chart Receive AAPG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AAPG) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
